Optimization of <scp>CRISPR–Cas</scp> system for clinical cancer therapy-Reference-Cited by-同舟云学术

Optimization of CRISPR–Cas system for clinical cancer therapy

Published:2022-12-23 Issue:2 Volume:8 Page:
ISSN:2380-6761
Container-title:Bioengineering & Translational Medicine
language:en
Short-container-title:Bioengineering & Transla Med

Author:

Meng Xiang¹,Wu Tian‐gang¹,Lou Qiu‐yue²,Niu Kai‐yuan³⁴,Jiang Lei¹,Xiao Qing‐zhong³,Xu Tao⁵⁶,Zhang Lei¹⁷^ORCID

Affiliation:

1. College & Hospital of Stomatology Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province Hefei People's Republic of China

2. Anhui Provincial Center for Disease Control and Prevention Hefei People's Republic of China

3. Clinical Pharmacology, William Harvey Research Institute (WHRI), Barts and The London School of Medicine and Dentistry Queen Mary University of London (QMUL) Heart Centre (G23) London UK

4. Department of Otolaryngology The Third Affiliated Hospital of Anhui Medical University Hefei China

5. School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products Anhui Medical University Hefei China

6. Inflammation and Immune Mediated Diseases Laboratory of Anhui Province Hefei China

7. Department of Periodontology Anhui Stomatology Hospital Affiliated to Anhui Medical University Hefei China

Funder

National Natural Science Foundation of China

University Natural Science Research Project of Anhui Province

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/btm2.10474

Reference235 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis

3. The role of non‐coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential

4. International network of cancer genome projects

5. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The CRISPR Revolution: Unraveling the mysteries of Life’s genetic code;Gene;2024-01

2. Advanced strategies for CRISPR/Cas9 delivery and applications in gene editing, therapy, and cancer detection using nanoparticles and nanocarriers;Journal of Materials Chemistry B;2024

3. Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy;Bioengineering & Translational Medicine;2023-07-10